Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort: determinants and consequences
GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 April 2021
|
| In: |
The International journal of chronic obstructive pulmonary disease
Year: 2021, Volume: 16, Pages: 987-998 |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S304532 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S304532 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/treatment-of-copd-groups-gold-a-and-b-with-inhaled-corticosteroids-in--peer-reviewed-fulltext-article-COPD |
| Author Notes: | Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1758076828 | ||
| 003 | DE-627 | ||
| 005 | 20230427100714.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210518s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/COPD.S304532 |2 doi | |
| 035 | |a (DE-627)1758076828 | ||
| 035 | |a (DE-599)KXP1758076828 | ||
| 035 | |a (OCoLC)1341413364 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lutter, Johanna I. |d 1993- |e VerfasserIn |0 (DE-588)1225422418 |0 (DE-627)1745063129 |4 aut | |
| 245 | 1 | 0 | |a Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort |b determinants and consequences |c Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group |
| 264 | 1 | |c 14 April 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.05.2021 | ||
| 520 | |a GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more. | ||
| 700 | 1 | |a Jörres, Rudolf A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trudzinski, Franziska |d 1976- |e VerfasserIn |0 (DE-588)1145072836 |0 (DE-627)100530047X |0 (DE-576)495615579 |4 aut | |
| 700 | 1 | |a Alter, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kellerer, Christina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Watz, Henrik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Welte, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bals, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kauffmann-Guerrero, Diego |e VerfasserIn |4 aut | |
| 700 | 1 | |a Behr, Jürgen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holle, Rolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vogelmeier, Claus F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kahnert, Kathrin |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The International journal of chronic obstructive pulmonary disease |d Albany, Auckland : DOVE Medical Press, 2006 |g 16(2021), Seite 987-998 |h Online-Ressource |w (DE-627)504104357 |w (DE-600)2212419-6 |w (DE-576)312706367 |x 1178-2005 |7 nnas |a Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort determinants and consequences |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g pages:987-998 |g extent:12 |a Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort determinants and consequences |
| 856 | 4 | 0 | |u https://doi.org/10.2147/COPD.S304532 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.dovepress.com/treatment-of-copd-groups-gold-a-and-b-with-inhaled-corticosteroids-in--peer-reviewed-fulltext-article-COPD |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210518 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1145072836 |a Trudzinski, Franziska |m 1145072836:Trudzinski, Franziska |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1145072836 |e 950000PT1145072836 |e 950900PT1145072836 |e 50000PT1145072836 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1758076828 |e 3929422638 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"504104357","note":["Gesehen am 02.11.09"],"id":{"issn":["1178-2005"],"eki":["504104357"],"zdb":["2212419-6"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort determinants and consequencesThe International journal of chronic obstructive pulmonary disease","language":["eng"],"part":{"volume":"16","year":"2021","extent":"12","pages":"987-998","text":"16(2021), Seite 987-998"},"title":[{"title_sort":"International journal of chronic obstructive pulmonary disease","title":"The International journal of chronic obstructive pulmonary disease"}],"titleAlt":[{"title":"International journal of COPD"}],"pubHistory":["1.2006 -"],"origin":[{"dateIssuedDisp":"2006-","publisher":"DOVE Medical Press","publisherPlace":"Albany, Auckland","dateIssuedKey":"2006"}]}],"name":{"displayForm":["Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group"]},"language":["eng"],"recId":"1758076828","note":["Gesehen am 18.05.2021"],"id":{"doi":["10.2147/COPD.S304532"],"eki":["1758076828"]},"person":[{"display":"Lutter, Johanna I.","family":"Lutter","roleDisplay":"VerfasserIn","given":"Johanna I.","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Rudolf A.","role":"aut","display":"Jörres, Rudolf A.","family":"Jörres"},{"display":"Trudzinski, Franziska","family":"Trudzinski","roleDisplay":"VerfasserIn","given":"Franziska","role":"aut"},{"family":"Alter","display":"Alter, Peter","role":"aut","given":"Peter","roleDisplay":"VerfasserIn"},{"display":"Kellerer, Christina","family":"Kellerer","roleDisplay":"VerfasserIn","given":"Christina","role":"aut"},{"family":"Watz","display":"Watz, Henrik","role":"aut","roleDisplay":"VerfasserIn","given":"Henrik"},{"role":"aut","given":"Tobias","roleDisplay":"VerfasserIn","family":"Welte","display":"Welte, Tobias"},{"given":"Robert","roleDisplay":"VerfasserIn","role":"aut","display":"Bals, Robert","family":"Bals"},{"role":"aut","given":"Diego","roleDisplay":"VerfasserIn","family":"Kauffmann-Guerrero","display":"Kauffmann-Guerrero, Diego"},{"display":"Behr, Jürgen","family":"Behr","role":"aut","roleDisplay":"VerfasserIn","given":"Jürgen"},{"role":"aut","given":"Rolf","roleDisplay":"VerfasserIn","family":"Holle","display":"Holle, Rolf"},{"family":"Vogelmeier","display":"Vogelmeier, Claus F.","role":"aut","roleDisplay":"VerfasserIn","given":"Claus F."},{"given":"Kathrin","roleDisplay":"VerfasserIn","role":"aut","display":"Kahnert, Kathrin","family":"Kahnert"}],"physDesc":[{"extent":"12 S."}],"title":[{"subtitle":"determinants and consequences","title_sort":"Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort","title":"Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"14 April 2021","dateIssuedKey":"2021"}]} | ||
| SRT | |a LUTTERJOHATREATMENTO1420 | ||